Sprout Health GLP-1 Review vs PlexusDx (2026): Cost, Safety & Verdict | PlexusDx

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

Sprout Health markets compounded semaglutide at $249/mo and compounded tirzepatide at $299/mo, with a $50-off first-month code, a price-lock as the dose escalates, and a 44-state footprint that excludes Alabama, Arkansas, California, Louisiana, Mississippi, and North Dakota. The platform is LegitScript-certified, ships in 3–7 business days after prescription approval, and the most consistent customer complaints are about slow support rather than missing medication. This review walks the actual pricing math, the medication-source question (compounded vs FDA-approved branded), the customer-service tradeoff, the state-availability gap, and where PlexusDx Semaglutide Injection at $149/mo, Tirzepatide Injection at $249/mo, and the Microdose GLP-1 Protocol at $129/mo flat sit relative to Sprout — including the six states Sprout doesn't cover.

Sprout Health GLP-1 review — the bottom line

Sprout Health is a legitimate cash-pay telehealth platform: real LLC (Sprout Health Partners, Encinitas, California), MD Integrations provider network, U.S. 503A compounding pharmacy partners, LegitScript certification, and thousands of customers who report receiving medication and losing weight. The two real tradeoffs are (1) customer support is slow — portal messages and emails frequently take days, phone goes to voicemail — and (2) compounded semaglutide and tirzepatide are not FDA-approved finished products. Both tradeoffs apply to most cash-pay compounded GLP-1 platforms in 2026, so the comparison that matters is Sprout vs other compounded providers (including PlexusDx Weight Management Protocols) and Sprout vs branded telehealth (Wegovy/Zepbound). On price, Sprout sits in the middle of the compounded market — cheaper than premium-branded routes, more expensive than PlexusDx's Microdose GLP-1 Protocol at $129/mo, and roughly $20–$70/mo above PlexusDx's Semaglutide Injection tier.

Sprout Health pricing vs PlexusDx

Sprout's published pricing as of January 2026: compounded semaglutide is $249/mo monthly or roughly $205/mo on the 3-month plan ($615 total); compounded tirzepatide is $299/mo monthly or roughly $250/mo on the 3-month plan ($750 total). The FIRST50 promo takes $50 off your first month. Year-one totals: about $2,938 monthly semaglutide, $3,538 monthly tirzepatide, $2,460 semaglutide 3-month, $3,000 tirzepatide 3-month. The fee covers clinician evaluation, video consult if your state requires one, prescription, 4-week medication supply, syringes, supplies, shipping, and patient-portal access. The price-lock as your dose escalates is a genuine advantage; many competitors charge $50–$150 more per month at higher dose levels.

PlexusDx Weight Management Protocols are also all-inclusive cash-pay with no membership: Microdose GLP-1 Protocol at $129/mo flat (about $1,548/year), Semaglutide Injection at $149/mo across five dose levels (0.25mg to 2.0mg weekly), Tirzepatide Injection at $249/mo across six dose levels (2.5mg to 15mg weekly), and GLP-Squared dual-compound at $249/mo. Add the Precision Peptide Genetic Test for $99 as an add-on after your first month and the genetic-baseline-included totals stay below Sprout's monthly tier on most pairings.

Compounded vs FDA-approved branded medications

Sprout dispenses compounded semaglutide and compounded tirzepatide — pharmacy-prepared formulations of the same active ingredients in Wegovy, Ozempic, Mounjaro, and Zepbound, prepared by U.S. 503A state-licensed compounding pharmacies under USP standards. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products; the FDA has not reviewed the specific compounded formulations for safety, effectiveness, or quality the way it reviews Wegovy or Zepbound. Branded products carry FDA labels, post-market surveillance, and the SUSTAIN, STEP, and SURMOUNT trial data that anchor their effect-size claims; compounded products carry the same active ingredient at pharmacist-determined formulation. PlexusDx Weight Management Protocols use the same compounded model as Sprout but offer four delivery formats — weekly injection, daily oral tablet, microdose troche/capsule/lozenge/sublingual, and dual-compound stacks. Neither platform can call its compounded products FDA-approved, and any platform that does is misrepresenting the regulatory status.

Customer service and clinical oversight

The most consistent theme across Sprout reviews is that support response times are slow. Email turnaround is frequently 2–5 business days; the listed phone line at 833-496-4020 routes to voicemail; the patient portal is generally the fastest path. Customers who order, receive their medication, and don't need to contact support tend to write positive reviews; customers who need to ask a question, change a dose, or troubleshoot a shipment frequently report frustration. Sprout's clinical oversight is delivered through MD Integrations — licensed physicians, NPs, and PAs — with a video visit when state regulations require one. PlexusDx Weight Management Protocols use licensed U.S. compounding pharmacies and a clinical team that, when the genetic test is included, reviews the patient's GLP1R, FTO, MC4R, GIPR, and TCF7L2 variants before titration — a stratification step Sprout does not currently offer. If support responsiveness is a priority, PlexusDx Semaglutide Injection or Tirzepatide Injection — with async provider messaging through the PlexusDx Results Portal — may fit the workflow better.

Safety, side effects, and the boxed warning

Sprout, like any GLP-1 telehealth platform, prescribes medications in the GLP-1 receptor-agonist class (semaglutide) and the GIP/GLP-1 dual-agonist class (tirzepatide). The labeled side-effect profile is well-characterized: nausea, vomiting, diarrhea, constipation, abdominal pain, and headache are common, especially during dose escalation; pancreatitis, gallbladder disease, and acute kidney injury are less common but documented; the boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies, so a personal or family history of medullary thyroid carcinoma or MEN-2 is a contraindication for both. These warnings apply regardless of whether the active ingredient is dispensed as compounded (Sprout, PlexusDx) or branded (Wegovy, Zepbound). Discuss your full medication list and family history with the prescribing clinician on either platform before titration.

State availability: the six-state gap

Sprout serves 44 states and explicitly does not serve Alabama, Arkansas, California, Louisiana, Mississippi, or North Dakota. California is the headline exclusion — the most populous state in the country — driven by California's specific compounding-pharmacy regulations and provider-licensing rules. If you live in any of those six states, Sprout is not an option. PlexusDx Weight Management Protocols are available in all 50 states, with five states requiring a scheduled live consultation rather than async intake. For California, Alabama, Arkansas, Louisiana, Mississippi, or North Dakota residents who specifically wanted compounded semaglutide or tirzepatide and were turned away from Sprout, PlexusDx Semaglutide Injection and PlexusDx Tirzepatide Injection are direct alternatives.

Why genetics matter before you pick a platform

GLP-1 response varies meaningfully across patients. Variants in GLP1R (the GLP-1 receptor), GIPR (the GIP receptor — relevant specifically to tirzepatide's dual-agonist mechanism), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide. The Precision Peptide Genetic Test maps 48 unique genes and 57 genetic variants across 14 health pathways — including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response — delivered through the Peptide Pathways Report in the PlexusDx Results Portal. The clinical question this test answers isn't whether GLP-1 will work; it's whether semaglutide or tirzepatide is a better biological fit and how aggressively to titrate. Sprout starts every patient from a population-average titration schedule. PlexusDx anchors that conversation to a measurable genetic baseline — $298 standalone or $99 as an add-on after your first month on any protocol.

Sprout vs PlexusDx — head-to-head and verdict

Pricing structure: Both are all-inclusive cash-pay with no insurance billing and no membership fees. Sprout is $249/mo semaglutide, $299/mo tirzepatide. PlexusDx is $129/mo for the Microdose GLP-1 Protocol, $149/mo for Semaglutide Injection, $249/mo for Tirzepatide Injection, and $249/mo for GLP-Squared. State coverage: Sprout 44; PlexusDx all 50. Medication source: Both U.S. 503A compounding pharmacies; neither FDA-approved. Delivery formats: Sprout offers weekly injection only. PlexusDx offers weekly injection, daily oral tablet (Semaglutide Oral and Tirzepatide Oral), microdose, and dual-compound stacks. Genetic stratification: Sprout no; PlexusDx yes via the Precision Peptide Genetic Test. Verdict: Sprout is a reasonable fit for self-sufficient buyers in covered states who don't need responsive support. If you live in California, Alabama, Arkansas, Louisiana, Mississippi, or North Dakota, want a non-injection format, want the lowest-cost compounded entry, or want a genetic baseline before week one, PlexusDx fits better.

Frequently asked questions

Is Sprout Health legit?

Yes. Sprout Health Partners LLC is a real telehealth company headquartered in Encinitas, California, LegitScript-certified, partnered with licensed clinicians through MD Integrations and U.S. 503A compounding pharmacies. The complaints you'll find online cluster around slow customer service, not on missing medications or fraud.

Are Sprout Health's medications FDA-approved?

No. Sprout dispenses compounded semaglutide and compounded tirzepatide, which are pharmacy-prepared formulations not reviewed by the FDA for safety, effectiveness, or quality. This is true across the entire compounded GLP-1 segment, including PlexusDx Weight Management Protocols. Only branded finished products like Wegovy, Ozempic, Zepbound, and Mounjaro are FDA-approved.

How much does Sprout Health cost compared with PlexusDx?

Sprout charges $249/mo for compounded semaglutide and $299/mo for compounded tirzepatide. PlexusDx prices the Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection at $149/mo, and Tirzepatide Injection at $249/mo — cheaper at the entry tiers and competitive at the higher dose tiers.

Does Sprout Health serve California?

No. Sprout does not serve California, Alabama, Arkansas, Louisiana, Mississippi, or North Dakota. PlexusDx Weight Management Protocols are available in all 50 states, with five states requiring a scheduled live consult rather than async intake.

Is compounded semaglutide the same as Ozempic or Wegovy?

No. Compounded semaglutide is a pharmacy-prepared formulation that uses the same active ingredient but is not FDA-approved and is not a generic of Ozempic or Wegovy. Novo Nordisk does not manufacture compounded semaglutide. The same distinction applies to compounded tirzepatide vs Mounjaro and Zepbound.

What if Sprout's customer service is too slow for me?

Customer-service responsiveness is the most consistent Sprout complaint. If you anticipate needing frequent provider messaging or expect prompt support during dose titration, an alternative like PlexusDx Semaglutide Injection or Tirzepatide Injection — with async provider messaging through the PlexusDx Results Portal — may fit better.

Can my genetics tell me whether semaglutide or tirzepatide is better for me?

Yes, partially. Variants in GLP1R, GIPR, FTO, MC4R, and TCF7L2 are associated with measurably different response patterns to GLP-1 and GIP/GLP-1 therapy. The PlexusDx Precision Peptide Genetic Test maps 48 genes and 57 variants across 14 pathways — including 34 weight-management insights and the GIPR rs1800437 variant — for $298 standalone or $99 as an add-on after your first month on any protocol.

Related reading on PlexusDx: GLP-1 Cost, Semaglutide Cost, Tirzepatide Costs, Cheapest GLP-1.

Disclaimer: This article is educational and is not medical advice. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols. Pricing for Sprout Health is based on the provider's published rates as of January 2026; actual costs may vary by state, plan, and individual eligibility. PlexusDx does not sell, prescribe, or recommend any therapeutic peptide outside the GLP-1 category covered by its protocols. Discuss any GLP-1 medication decision with a licensed clinician.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.